Search Results - barry+byrne

2 Results Sort By:
Improved Gene Therapy Vectors for the Treatment of Glycogen Storage Disease Type Ia (GSD-1a)
Summary: NICHD is seeking licensees for development of an adeno-associated viral (AAV) vectors for the treatment of glycogen storage disease type Ia (GSD-Ia). Description of Technology: GSD-Ia is an inherited disorder of metabolism associated with life-threatening hypoglycemia, hepatic malignancy, and renal failure caused by the deficiency of glucose-6-phosphatase-alpha...
Published: 4/24/2026   |   Updated: 8/2/2023   |   Inventor(s): Janice Chou, Barry Byrne
Keywords(s): Chou, GSD-1a, hepatic malignancy, hyperlipidemia, hypoglycemia, National Institute of Child Health and Human Development, NICHD
Category(s): TherapeuticArea > Nephrology, Application > Therapeutics, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, TherapeuticArea > Endocrinology
Improved Large Scale Production of Adeno-Associated Viruses
Enables a More Efficient and More Potent Production of AAV VectorsThis production of highly concentrated and potent Adeno-Associated Virus (AAV) vectors has significant advantage over available protocol and allows for large-scale manufacturing of the virus. More than 6 percent of all gene therapy clinical trials worldwide use AAV vectors due to their...
Published: 1/20/2026   |   Updated: 5/17/2019   |   Inventor(s): Barry Byrne, Laura Adamson, Nathalie Clement
Keywords(s): AAV, Gene Therapy, HEK293, HSV
Category(s): Technology Classifications > Human Health Care > Gene Therapy